Navigation Links
Cardiome meldet Veröffentlichung positiver Ergebnisse aus Vergleichsstudie von Vernakalant IV mit Propafenon und Flecainid
Date:9/24/2013

? Journal of Atrial Fibrillation. 2013;6(2). Online-Zugriff am 17. September 2013

Informationen zur Cardiome Pharma Corp.

Die Cardiome Pharma Corp. ist ein Biopharmaunternehmen, das sich der Entdeckung, Entwicklung und Vermarktung von neuen Therapien verschrieben hat, die der Gesundheit von Patienten aus aller Welt zugutekommen. Das einzige von Cardiome vermarktete Produkt BRINAVESS[TM] (Vernakalant IV) ist in Europa und anderen Gebieten zur raschen Konversion von jüngst ausgebrochenem Vorhofflimmern zum Sinusrhythmus bei Erwachsenen zugelassen.

Die Aktien von Cardiome sind am NASDAQ Capital Market (CRME) und an der Börse Toronto (COM) gelistet. Nähere Informationen erhalten Sie auf unserer Website http://www.cardiome.com.

Haftungsausschluss in Bezug auf vorausschauende Aussagen

Bestimmte Aussagen in dieser Pressemitteilung enthalten vorausschauende Aussagen im Sinne des Private Securities Litigation Reform Act von 1995 bzw. zukunftsgerichtete Informationen im Sinne gültiger kanadischer Wertpapiergesetze, die unter Umständen nicht auf historischen Tatsachen beruhen. Ohne jegliche Einschränkung zählen hierzu Aussagen, die die Begriffe "glauben", "können", "planen", "werden", "schätzen", "weiterhin", "antizipieren", "beabsichtigen, "erwarten" sowie ähnliche Formulierungen enthalten. Vorausschauende Aussagen können unter Umständen Bemerkungen bezüglich unserer Ziele und Prioritäten für den verbleibenden Teil des Jahres 2013 und darüber hinaus enthalten, sind aber nicht auf solche beschränkt. Zudem können sie sich auf Strategien und zukünftige Maßnahmen, Zielvorgaben, Erwartungen bezüglich unserer finanziellen Lage sowie auf die Ergebnisse und Prognosen unserer Geschäfts-, Forschungs- und Entwicklungsaktivitäten und unserer
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical Implications of Newly FDA-Approved Treatment for Homozygous Familial Hypercholesterolemia
2. Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... OMICS Group’s 5th International conference and ... 2014 at Double Tree by Hilton Beijing, China is ... Analytical & Bioanalytical research methods only to facilitate improved ... occasion, Dr. Srinubabu Gedela, MD of OMICS Group Inc ... remarkable one in bringing a unique and international mix ...
(Date:7/10/2014)... POINT, Ind. , July 10, 2014 ... expanded its use of capnography for respiratory ... growing group of healthcare leaders in embracing ... measures how effectively patients are breathing and ... depression occurs. By measuring the amount of ...
(Date:7/10/2014)... Utah , July 10, 2014 /PRNewswire-iReach/ ... annotation and interpretation, today announced an agreement ... (NGS) analytics for Lineagen,s NextStep Dx ... of neurodevelopmental and neurological disorders, currently offers ... microarray (CMA) testing service used by healthcare ...
(Date:7/10/2014)... to the International Atomic Energy Agency (IAEA) the ... acquiring sufficient quantities of plutonium or highly enriched ... device. The IAEA also notes that most cases ... which can be challenging to detect with most ... appearing this week in the Journal of ...
Breaking Biology Technology:A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Franciscan St. Anthony Health-Crown Point Underscores Patient Safety Commitment Through Expanded Use of Capnography 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 2Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 3Tute Genomics Platform Selected to Provide Clinical Interpretation for Lineagen's NextStepDx PLUS Next-Generation Sequencing-Based Diagnostic Test 4Sensitive detection method may help impede illicit nuclear trafficking 2
... April 26 ChromaDex Corporation (OTC Bulletin Board: ... and innovative ingredients to the dietary supplement, food, beverage ... pterostilbene(tero-STILL-bean). This exciting new product introduction is based on ... patent rights of pterostilbene from the University of ...
... ... 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields , ... Oceanside, CA (PRWEB) April ... Corporation, and the market leader in solid support for oligonucleotide synthesis, will be launching ...
... April 26 Transgenomic, Inc. (OTC Bulletin Board: ... the company as Technical Director for Laboratory Services.  Dr. Richardson will be ... will report to Craig Tuttle , Transgenomic,s president and chief executive ... Dr. Richardson has ...
Cached Biology Technology:ChromaDex Launches pTeroPure Pterostilbene 2ChromaDex Launches pTeroPure Pterostilbene 3ChromaDex Launches pTeroPure Pterostilbene 4ChromaDex Launches pTeroPure Pterostilbene 5Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis 2Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis 3Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis 4Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services 2Transgenomic Names Dr. Katherine Richardson Technical Director for Laboratory Services 3
(Date:7/10/2014)... In Santa Fe, Albuquerque, and other major cities in ... watered with treated municipal wastewater rather than precious potable ... more than 40% of all golf courses receive treated ... courses. , Additionally, golf courses and homeowners alike ... nutrient in fertilizer is nitrate. A New Mexico State ...
(Date:7/10/2014)...  Aware, Inc. (NASDAQ: AWRE ), a ... on June 26, 2014 that its Board of Directors ... share, or approximately $40 million in total.  The Board ... a payment date of July 24, 2014.  The Company ... an ex-dividend date for this special cash dividend.  An ...
(Date:7/10/2014)... , July 2, 2014 It is a ... announce the appointment of the world-renowned Thoracic and Cardiovascular ... Directors. Dr. Ginsburg, with over 34 years ... Presbyterian Hospital and Good Samaritan Regional Medical Center. Dr. ... the late 1980,s and is considered an expert in ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2NASDAQ Sets Ex-Dividend Date for Aware, Inc.'s Special Cash Dividend of $1.75 Per Share 2Avery Biomedical Devices, Inc. announces the appointment of Mark E Ginsburg, M.D. to its Board of Directors 2
... animals contain a large number of different bacteria. Humans are ... to a vast range of unicellular organisms, many of which ... no ill effects other than consuming some of the food ... Among them is Helicobacter pylori , which may play ...
... the ribosome represents the machinery necessary to assemble proteins, ... encoded in the genome,s DNA is first transcribed to ... ribosome where protein-assembly instructions are put in motion to ... recent years, it has been demonstrated that the ribosome ...
... Baltimore, MD September 18, 2013 Scientists at ... Vaccine Development are part of nationwide vaccine research aimed ... of avian (bird) influenza (flu) virus. The virus, called ... of mid-August, 135 confirmed human cases, including 44 deaths, ...
Cached Biology News:Getting rid of unwanted visitors 2Global analysis reveals new insights into the ribosome -- with important implications for disease 2Global analysis reveals new insights into the ribosome -- with important implications for disease 3Global analysis reveals new insights into the ribosome -- with important implications for disease 4University of Maryland researchers studying vaccine to prevent potential bird flu pandemic 2University of Maryland researchers studying vaccine to prevent potential bird flu pandemic 3
Monoclonal Antibody to GLP Immunogen: Ni-NTA purified truncated recombinant GLP expressed in E. Coli strain BL21 (DE3)...
...
Homo sapiens MEP50 protein, mRNA...
Co-precipitant is free of background polynucleotides,Dnases,Rnases, proteases. 20mg/ml...
Biology Products: